Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

813 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 813 results

Post-approval studies (Phase 4)Study completedNCT00806234
What this trial is testing

Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics

Who this might be right for
Psychotic Disorders
Johns Hopkins University 127
Not applicableUnknownNCT04064476
What this trial is testing

The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk

Who this might be right for
Schizophrenia
Huazhong University of Science and Technology 225
Early research (Phase 1)Study completedNCT00796835
What this trial is testing

A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 50
Post-approval studies (Phase 4)Looking for participantsNCT06740890
What this trial is testing

Exercise and Olanzapine-samidorphan

Who this might be right for
Schizophenia DisorderSchizoaffective DisorderBipolar Disorder I or II+1 more
New York State Psychiatric Institute 30
Not applicableEnded earlyNCT00885690
What this trial is testing

Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)

Who this might be right for
Schizophrenia
University of Aarhus 11
Post-approval studies (Phase 4)Study completedNCT00817648
What this trial is testing

Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 120
Not applicableStudy completedNCT02504450
What this trial is testing

Outcomes of Antipsychotic Medication Used in the Emergency Department

Who this might be right for
Agitation,Psychomotor
Wake Forest University Health Sciences 93
Not applicableStudy completedNCT02409823
What this trial is testing

Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

Who this might be right for
SchizophreniaMajor Depressive DisorderBipolar Depressive Disorder+1 more
Pontifical Catholic University of Argentina 665
Large-scale testing (Phase 3)Study completedNCT01235559
What this trial is testing

RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 604
Large-scale testing (Phase 3)Study completedNCT00240708
What this trial is testing

The Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Pharmaceutical K.K. 205
Very early researchStudy completedNCT03430596
What this trial is testing

A Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics

Who this might be right for
Extrapyramidal Syndrome
Shanghai Mental Health Center 50
Large-scale testing (Phase 3)Study completedNCT00420823
What this trial is testing

Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment

Who this might be right for
Psychotic Disorders
Melbourne Health 121
Not applicableStudy completedNCT03537040
What this trial is testing

Piloting MOL Intervention for Neuroleptic Decision Making

Who this might be right for
PsychosisMedication Adherence
University of Manchester 5
Large-scale testing (Phase 3)Study completedNCT02610868
What this trial is testing

Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults

Who this might be right for
Sialorrhea
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187
Early research (Phase 1)Study completedNCT01903200
What this trial is testing

Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder Patients
Astellas Pharma Inc 16
Early research (Phase 1)Study completedNCT00796471
What this trial is testing

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35
Post-approval studies (Phase 4)Study completedNCT00188942
What this trial is testing

A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

Who this might be right for
Major Depressive Disorder
University Health Network, Toronto 42
Early research (Phase 1)Study completedNCT02087579
What this trial is testing

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

Who this might be right for
Psychotic DisordersSchizophreniaBipolar Disorder+1 more
Janssen Research & Development, LLC 305
Large-scale testing (Phase 3)Study completedNCT01626859
What this trial is testing

A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 38
Not applicableStudy completedNCT00636896
What this trial is testing

Effects of Modafinil on Olanzapine Weight Gain

Who this might be right for
Weight Gain
Neuropsychiatric Research Institute, Fargo, North Dakota 50
Next Page